We are live on ! Find out more
EM

Excalibur Management Portfolio holdings

AUM $278M
1-Year Est. Return 20.09%
This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+20.09%
3 Year Est. Return
+68.93%
5 Year Est. Return
+93.63%
10 Year Est. Return
+240.99%
AUM
$91.7M
AUM Growth
+$6.5M
Cap. Flow
-$70.5K
Cap. Flow %
-0.08%
Top 10 Hldgs %
62.27%
Holding
62
New
2
Increased
11
Reduced
23
Closed
2

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$581K
2
EMC
EMC CORPORATION
EMC
+$268K
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$224K
4
KMB icon
Kimberly-Clark
KMB
+$213K
5
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$202K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$301K
2
BMY icon
Bristol-Myers Squibb
BMY
+$288K
3
CSL icon
Carlisle Companies
CSL
+$247K
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$217K
5
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$210K

Sector Composition

Rank Sector Weight
1 Healthcare 23.15%
2 Communication Services 18.78%
3 Industrials 15.74%
4 Technology 9.56%
5 Consumer Staples 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
1
AT&T
T
$169B
$9.01M 9.83%
339,398
+4,415
+1% +$116K
CSL icon
2
Carlisle Companies
CSL
$14.1B
$8.63M 9.41%
108,680
-3,369
-3% -$247K
VZ icon
3
Verizon
VZ
$201B
$7.94M 8.66%
161,542
+1,010
+0.6% +$49.7K
JNJ icon
4
Johnson & Johnson
JNJ
$643B
$6.02M 6.57%
65,738
-2,235
-3% -$206K
PFE icon
5
Pfizer
PFE
$144B
$5.95M 6.49%
204,885
-3,578
-2% -$104K
GE icon
6
GE Aerospace
GE
$377B
$5.19M 5.66%
38,627
+407
+1% +$51.3K
MRK icon
7
Merck
MRK
$326B
$5.09M 5.55%
106,620
-944
-0.9% -$43.2K
XOM icon
8
ExxonMobil
XOM
$634B
$3.67M 4%
36,271
-5
-0% -$462
MSFT icon
9
Microsoft
MSFT
$2.92T
$3.12M 3.41%
83,442
-1,150
-1% -$41.8K
PEP icon
10
PepsiCo
PEP
$195B
$2.46M 2.68%
29,649
-138
-0.5% -$11.5K
BRK.B icon
11
Berkshire Hathaway Class B
BRK.B
$1.11T
$2.44M 2.66%
20,538
+1,940
+10% +$224K
IBM icon
12
IBM
IBM
$214B
$2.13M 2.32%
11,861
+3,370
+40% +$581K
INDB icon
13
Independent Bank
INDB
$4.1B
$2M 2.18%
51,105
– –
PG icon
14
Procter & Gamble
PG
$347B
$1.95M 2.13%
23,946
-475
-2% -$38.7K
KO icon
15
Coca-Cola
KO
$380B
$1.88M 2.06%
45,612
+2,560
+6% +$101K
SPY icon
16
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$1.82M 1.99%
9,856
+676
+7% +$120K
EMC
17
DELISTED
EMC CORPORATION
EMC
$1.49M 1.63%
59,290
+11,075
+23% +$268K
SO icon
18
Southern Company
SO
$109B
$1.35M 1.47%
32,806
-555
-2% -$22.9K
DUK icon
19
Duke Energy
DUK
$101B
$1.2M 1.31%
17,396
+168
+1% +$11.8K
COP icon
20
ConocoPhillips
COP
$139B
$1.09M 1.19%
15,445
-175
-1% -$12.6K
BMY icon
21
Bristol-Myers Squibb
BMY
$130B
$1.07M 1.17%
20,165
-5,650
-22% -$288K
KMP
22
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$976K 1.06%
12,105
-200
-2% -$16.1K
AMGN icon
23
Amgen
AMGN
$212B
$901K 0.98%
7,900
– –
INTC icon
24
Intel
INTC
$435B
$886K 0.97%
34,141
-8,433
-20% -$204K
PM icon
25
Philip Morris
PM
$312B
$789K 0.86%
9,051
-190
-2% -$16.6K
1
2 3

Similar funds

DI
Disciplined Investments Tulsa, Oklahoma $279M AUM 18.21% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
CB
Centennial Bank Conway, Arkansas $279M AUM 20.11% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
LJCM
Lee Johnson Capital Management Fort Worth, Texas $279M AUM 40.65% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
RW
Rede Wealth Charlottesville, Virginia $278M AUM 9.19% 1-Year Est. Return

Excalibur Management's Q4 2013 Portfolio in Review

As of Q4 2013, Excalibur Management held 62 positions worth $91.7M, up 7.6% from $85.2M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Excalibur Management's Q4 2013 filing shows 2 new, 11 increased, 23 reduced and 2 closed positions. Its largest new stake was Kimberly-Clark: 2,138 shares worth $214K. The largest sale was AbbVie, an estimated $301K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Communication Services and Industrials.

  • Excalibur Management's largest Q4 2013 buy was Kimberly-Clark: 2,138 shares worth $214K.
  • Excalibur Management added most to IBM in Q4 2013, an estimated $581K increase.
  • Excalibur Management's biggest Q4 2013 reduction was AbbVie, cutting an estimated $301K.
  • Excalibur Management fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2013, selling an estimated $217K.
  • Excalibur Management's ten largest holdings make up 62% of its $91.7M portfolio in Q4 2013.
  • Excalibur Management opened 2 new positions and closed 2 in Q4 2013.
  • Excalibur Management's portfolio value rose 7.6% quarter-over-quarter to $91.7M.

Based on Excalibur Management's 13F filing for Q4 2013, filed 31 Jan 2014.